ヒト凝固第VIII因子の世界及び中国市場

• 英文タイトル：Global and China Human Coagulation Factor VIII Market Insights, Forecast to 2027

• レポートコード：QY2108PAL8852
• 出版社/出版日：QYResearch / 2021年7月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、149ページ
• 納品方法：Eメール（納期：1日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の当調査資料ではグローバルにおけるヒト凝固第VIII因子の市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、ヒト凝固第VIII因子の種類別市場規模（組換え第VIII因子、血漿由来第VIII因子）、用途別市場規模（血友病A、自発的/外傷、外科的、その他）も掲載しています。他に、北米・アメリカ市場、ヨーロッパ市場、アジア太平洋・日本市場、中南米市場、中東・アフリカ市場の市場規模、グローバル市場機会・課題・リスク要因、バリューチェーン・販売チャネル、主要プレイヤーの情報なども掲載しています。
・調査の概要
・調査のサマリー
・世界のヒト凝固第VIII因子市場動向
・グローバル主要プレイヤーの競争状況・市場シェア
・世界におけるヒト凝固第VIII因子の種類別市場規模（2016年-2027年）：組換え第VIII因子、血漿由来第VIII因子
・世界におけるヒト凝固第VIII因子の用途別市場規模（2016年-2027年）：血友病A、自発的/外傷、外科的、その他
・ヒト凝固第VIII因子の中国市場分析
- ヒト凝固第VIII因子の中国市場規模（2016年-2027年）
- 中国におけるヒト凝固第VIII因子の主要プレイヤー別市場シェア
- 中国におけるヒト凝固第VIII因子の種類別市場規模：組換え第VIII因子、血漿由来第VIII因子
- 中国におけるヒト凝固第VIII因子の用途別市場規模：血友病A、自発的/外傷、外科的、その他
・ヒト凝固第VIII因子の北米市場（2016年-2027年）
・ヒト凝固第VIII因子のヨーロッパ市場（2016年-2027年）
・ヒト凝固第VIII因子のアジア太平洋市場（2016年-2027年）
・ヒト凝固第VIII因子の中南米市場（2016年-2027年）
・ヒト凝固第VIII因子の中東・アフリカ市場（2016年-2027年）
・主要プレイヤーの情報：Shire (Baxter)、Bayer、CSL、Pfizer、Grifols、Biogen、Octapharma、NovoNordisk、Greencross、Kedrion、BPL、Hualan Bio、RAAS
・市場機会・課題・リスク要因分析
・バリューチェーン・販売チャネル分析
・...

Human Coagulation Factor VIII is an essential blood-clotting protein, also known as anti-hemophilic factor (AHF). In humans, factor VIII is encoded by the F8 gene, defects in this gene results in hemophilia A. Human Coagulation Factor VIII concentrated from donated blood plasma (Aafact or Alphanate, Monoclate-P®), or alternatively recombinant Human Coagulation Factor VIII can be given to hemophiliacs to restore hemostasis.
Global Human Coagulation Factor VIII key players include Baxter, Bayer, CSL, Pfizer, Biogen, etc. Global top five manufacturers hold a share about 80%. North America is the largest market, with a share about 60%, followed by Europe, with a share about 30 percent. In terms of product, Recombinant Factor VIII is the largest segment, with a share about 65%. And in terms of application, the largest application is Hemophilia A, followed by Spontanous / Trauma, Surgical, etc.

Market Analysis and Insights: Global and China Human Coagulation Factor VIII Market
This report focuses on global and China Human Coagulation Factor VIII market.
In 2020, the global Human Coagulation Factor VIII market size was US$ 9553 million and it is expected to reach US$ 14760 million by the end of 2027, with a CAGR of 6.3% during 2021-2027. In China the Human Coagulation Factor VIII market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Human Coagulation Factor VIII Scope and Market Size
Human Coagulation Factor VIII market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Human Coagulation Factor VIII market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Human Coagulation Factor VIII market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type
Recombinant Factor VIII
Plasma-derived Factor VIII

Segment by Application
Hemophilia A
Spontanous / Trauma
Surgical
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Shire (Baxter)
Bayer
CSL
Pfizer
Grifols
Biogen
Octapharma
NovoNordisk
Greencross
Kedrion
BPL
Hualan Bio
RAAS

レポート目次

1 Study Coverage
1.1 Human Coagulation Factor VIII Product Introduction
1.2 Market by Type
1.2.1 Global Human Coagulation Factor VIII Market Size Growth Rate by Type
1.2.2 Recombinant Factor VIII
1.2.3 Plasma-derived Factor VIII
1.3 Market by Application
1.3.1 Global Human Coagulation Factor VIII Market Size Growth Rate by Application
1.3.2 Hemophilia A
1.3.3 Spontanous / Trauma
1.3.4 Surgical
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Human Coagulation Factor VIII Market Size, Estimates and Forecasts
2.1.1 Global Human Coagulation Factor VIII Revenue 2016-2027
2.1.2 Global Human Coagulation Factor VIII Sales 2016-2027
2.2 Global Human Coagulation Factor VIII, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Human Coagulation Factor VIII Historical Market Size by Region (2016-2021)
2.3.1 Global Human Coagulation Factor VIII Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Human Coagulation Factor VIII Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Human Coagulation Factor VIII Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Human Coagulation Factor VIII Sales Forecast by Region (2022-2027)
2.4.2 Global Human Coagulation Factor VIII Revenue Forecast by Region (2022-2027)

3 Global Human Coagulation Factor VIII Competitor Landscape by Players
3.1 Global Top Human Coagulation Factor VIII Manufacturers by Sales
3.1.1 Global Human Coagulation Factor VIII Sales by Manufacturer (2016-2021)
3.1.2 Global Human Coagulation Factor VIII Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Human Coagulation Factor VIII Manufacturers by Revenue
3.2.1 Key Human Coagulation Factor VIII Manufacturers Covered: Ranking by Revenue
3.2.2 Global Human Coagulation Factor VIII Revenue by Manufacturers (2016-2021)
3.2.3 Global Human Coagulation Factor VIII Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Human Coagulation Factor VIII Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Human Coagulation Factor VIII Revenue in 2020
3.2.6 Global Human Coagulation Factor VIII Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Human Coagulation Factor VIII Price by Manufacturers
3.4 Global Human Coagulation Factor VIII Manufacturing Base Distribution, Product Types
3.4.1 Human Coagulation Factor VIII Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Human Coagulation Factor VIII Product Type
3.4.3 Date of International Manufacturers Enter into Human Coagulation Factor VIII Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Human Coagulation Factor VIII Market Size by Type (2016-2021)
4.1.1 Global Human Coagulation Factor VIII Sales by Type (2016-2021)
4.1.2 Global Human Coagulation Factor VIII Revenue by Type (2016-2021)
4.1.3 Human Coagulation Factor VIII Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Human Coagulation Factor VIII Market Size Forecast by Type (2022-2027)
4.2.1 Global Human Coagulation Factor VIII Sales Forecast by Type (2022-2027)
4.2.2 Global Human Coagulation Factor VIII Revenue Forecast by Type (2022-2027)
4.2.3 Human Coagulation Factor VIII Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Human Coagulation Factor VIII Market Size by Application (2016-2021)
5.1.1 Global Human Coagulation Factor VIII Sales by Application (2016-2021)
5.1.2 Global Human Coagulation Factor VIII Revenue by Application (2016-2021)
5.1.3 Human Coagulation Factor VIII Price by Application (2016-2021)
5.2 Human Coagulation Factor VIII Market Size Forecast by Application (2022-2027)
5.2.1 Global Human Coagulation Factor VIII Sales Forecast by Application (2022-2027)
5.2.2 Global Human Coagulation Factor VIII Revenue Forecast by Application (2022-2027)
5.2.3 Global Human Coagulation Factor VIII Price Forecast by Application (2022-2027)

6 China by Players, Type and Application
6.1 China Human Coagulation Factor VIII Market Size YoY Growth 2016-2027
6.1.1 China Human Coagulation Factor VIII Sales YoY Growth 2016-2027
6.1.2 China Human Coagulation Factor VIII Revenue YoY Growth 2016-2027
6.1.3 China Human Coagulation Factor VIII Market Share in Global Market 2016-2027
6.2 China Human Coagulation Factor VIII Market Size by Players (International and Local Players)
6.2.1 China Top Human Coagulation Factor VIII Players by Sales (2016-2021)
6.2.2 China Top Human Coagulation Factor VIII Players by Revenue (2016-2021)
6.3 China Human Coagulation Factor VIII Historic Market Review by Type (2016-2021)
6.3.1 China Human Coagulation Factor VIII Sales Market Share by Type (2016-2021)
6.3.2 China Human Coagulation Factor VIII Revenue Market Share by Type (2016-2021)
6.3.3 China Human Coagulation Factor VIII Price by Type (2016-2021)
6.4 China Human Coagulation Factor VIII Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Human Coagulation Factor VIII Sales Forecast by Type (2022-2027)
6.4.2 China Human Coagulation Factor VIII Revenue Forecast by Type (2022-2027)
6.4.3 China Human Coagulation Factor VIII Price Forecast by Type (2022-2027)
6.5 China Human Coagulation Factor VIII Historic Market Review by Application (2016-2021)
6.5.1 China Human Coagulation Factor VIII Sales Market Share by Application (2016-2021)
6.5.2 China Human Coagulation Factor VIII Revenue Market Share by Application (2016-2021)
6.5.3 China Human Coagulation Factor VIII Price by Application (2016-2021)
6.6 China Human Coagulation Factor VIII Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Human Coagulation Factor VIII Sales Forecast by Application (2022-2027)
6.6.2 China Human Coagulation Factor VIII Revenue Forecast by Application (2022-2027)
6.6.3 China Human Coagulation Factor VIII Price Forecast by Application (2022-2027)

7 North America
7.1 North America Human Coagulation Factor VIII Market Size YoY Growth 2016-2027
7.2 North America Human Coagulation Factor VIII Market Facts & Figures by Country
7.2.1 North America Human Coagulation Factor VIII Sales by Country (2016-2021)
7.2.2 North America Human Coagulation Factor VIII Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Human Coagulation Factor VIII Market Size YoY Growth 2016-2027
8.2 Asia Pacific Human Coagulation Factor VIII Market Facts & Figures by Region
8.2.1 Asia Pacific Human Coagulation Factor VIII Sales by Region (2016-2021)
8.2.2 Asia Pacific Human Coagulation Factor VIII Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam

9 Europe
9.1 Europe Human Coagulation Factor VIII Market Size YoY Growth 2016-2027
9.2 Europe Human Coagulation Factor VIII Market Facts & Figures by Country
9.2.1 Europe Human Coagulation Factor VIII Sales by Country (2016-2021)
9.2.2 Europe Human Coagulation Factor VIII Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Human Coagulation Factor VIII Market Size YoY Growth 2016-2027
10.2 Latin America Human Coagulation Factor VIII Market Facts & Figures by Country
10.2.1 Latin America Human Coagulation Factor VIII Sales by Country (2016-2021)
10.2.2 Latin America Human Coagulation Factor VIII Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Human Coagulation Factor VIII Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Human Coagulation Factor VIII Market Facts & Figures by Country
11.2.1 Middle East and Africa Human Coagulation Factor VIII Sales by Country (2016-2021)
11.2.2 Middle East and Africa Human Coagulation Factor VIII Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 Shire (Baxter)
12.1.1 Shire (Baxter) Corporation Information
12.1.2 Shire (Baxter) Description and Business Overview
12.1.3 Shire (Baxter) Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Shire (Baxter) Human Coagulation Factor VIII Products Offered
12.1.5 Shire (Baxter) Recent Development
12.2 Bayer
12.2.1 Bayer Corporation Information
12.2.2 Bayer Description and Business Overview
12.2.3 Bayer Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Bayer Human Coagulation Factor VIII Products Offered
12.2.5 Bayer Recent Development
12.3 CSL
12.3.1 CSL Corporation Information
12.3.2 CSL Description and Business Overview
12.3.3 CSL Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2016-2021)
12.3.4 CSL Human Coagulation Factor VIII Products Offered
12.3.5 CSL Recent Development
12.4 Pfizer
12.4.1 Pfizer Corporation Information
12.4.2 Pfizer Description and Business Overview
12.4.3 Pfizer Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Pfizer Human Coagulation Factor VIII Products Offered
12.4.5 Pfizer Recent Development
12.5 Grifols
12.5.1 Grifols Corporation Information
12.5.2 Grifols Description and Business Overview
12.5.3 Grifols Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Grifols Human Coagulation Factor VIII Products Offered
12.5.5 Grifols Recent Development
12.6 Biogen
12.6.1 Biogen Corporation Information
12.6.2 Biogen Description and Business Overview
12.6.3 Biogen Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Biogen Human Coagulation Factor VIII Products Offered
12.6.5 Biogen Recent Development
12.7 Octapharma
12.7.1 Octapharma Corporation Information
12.7.2 Octapharma Description and Business Overview
12.7.3 Octapharma Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Octapharma Human Coagulation Factor VIII Products Offered
12.7.5 Octapharma Recent Development
12.8 NovoNordisk
12.8.1 NovoNordisk Corporation Information
12.8.2 NovoNordisk Description and Business Overview
12.8.3 NovoNordisk Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2016-2021)
12.8.4 NovoNordisk Human Coagulation Factor VIII Products Offered
12.8.5 NovoNordisk Recent Development
12.9 Greencross
12.9.1 Greencross Corporation Information
12.9.2 Greencross Description and Business Overview
12.9.3 Greencross Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Greencross Human Coagulation Factor VIII Products Offered
12.9.5 Greencross Recent Development
12.10 Kedrion
12.10.1 Kedrion Corporation Information
12.10.2 Kedrion Description and Business Overview
12.10.3 Kedrion Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Kedrion Human Coagulation Factor VIII Products Offered
12.10.5 Kedrion Recent Development
12.11 Shire (Baxter)
12.11.1 Shire (Baxter) Corporation Information
12.11.2 Shire (Baxter) Description and Business Overview
12.11.3 Shire (Baxter) Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Shire (Baxter) Human Coagulation Factor VIII Products Offered
12.11.5 Shire (Baxter) Recent Development
12.12 Hualan Bio
12.12.1 Hualan Bio Corporation Information
12.12.2 Hualan Bio Description and Business Overview
12.12.3 Hualan Bio Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Hualan Bio Products Offered
12.12.5 Hualan Bio Recent Development
12.13 RAAS
12.13.1 RAAS Corporation Information
12.13.2 RAAS Description and Business Overview
12.13.3 RAAS Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2016-2021)
12.13.4 RAAS Products Offered
12.13.5 RAAS Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Human Coagulation Factor VIII Industry Trends
13.2 Human Coagulation Factor VIII Market Drivers
13.3 Human Coagulation Factor VIII Market Challenges
13.4 Human Coagulation Factor VIII Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Human Coagulation Factor VIII Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global Human Coagulation Factor VIII Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Recombinant Factor VIII
Table 3. Major Manufacturers of Plasma-derived Factor VIII
Table 4. Global Human Coagulation Factor VIII Market Size Growth Rate by Application (2021-2027) & (K Bottles)
Table 5. Global Human Coagulation Factor VIII Market Size by Region (K Bottles) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Human Coagulation Factor VIII Sales by Regions (2016-2021) & (K Bottles)
Table 7. Global Human Coagulation Factor VIII Sales Market Share by Regions (2016-2021)
Table 8. Global Human Coagulation Factor VIII Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Human Coagulation Factor VIII Sales Forecast by Region (2022-2027) & (K Bottles)
Table 10. Global Human Coagulation Factor VIII Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Human Coagulation Factor VIII Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Human Coagulation Factor VIII Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Human Coagulation Factor VIII Sales by Manufacturers (2016-2021) (K Bottles)
Table 14. Global Human Coagulation Factor VIII Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Human Coagulation Factor VIII Manufacturers by Revenue (US$ Million) in 2020
Table 16. Human Coagulation Factor VIII Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Human Coagulation Factor VIII Revenue Share by Manufacturers (2016-2021)
Table 18. Global Human Coagulation Factor VIII Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Human Coagulation Factor VIII by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Coagulation Factor VIII as of 2020)
Table 20. Key Manufacturers Human Coagulation Factor VIII Price (2016-2021) (USD/Bottle)
Table 21. Human Coagulation Factor VIII Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Human Coagulation Factor VIII Product Type
Table 23. Date of International Manufacturers Enter into Human Coagulation Factor VIII Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Human Coagulation Factor VIII Sales by Type (2016-2021) (K Bottles)
Table 26. Global Human Coagulation Factor VIII Sales Share by Type (2016-2021)
Table 27. Global Human Coagulation Factor VIII Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Human Coagulation Factor VIII Revenue Share by Type (2016-2021)
Table 29. Human Coagulation Factor VIII Average Selling Price (ASP) by Type (2016-2021) & (USD/Bottle)
Table 30. Global Human Coagulation Factor VIII Sales Forecast by Type (2022-2027) & (K Bottles)
Table 31. Global Human Coagulation Factor VIII Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Human Coagulation Factor VIII Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Human Coagulation Factor VIII Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Human Coagulation Factor VIII Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Bottle)
Table 35. Global Human Coagulation Factor VIII Sales by Application (2016-2021) (K Bottles)
Table 36. Global Human Coagulation Factor VIII Sales Share by Application (2016-2021)
Table 37. Global Human Coagulation Factor VIII Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Human Coagulation Factor VIII Revenue Share by Application (2016-2021)
Table 39. Human Coagulation Factor VIII Average Selling Price (ASP) by Application (2016-2021) & (USD/Bottle)
Table 40. Global Human Coagulation Factor VIII Sales Forecast by Application (2022-2027) & (K Bottles)
Table 41. Global Human Coagulation Factor VIII Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Human Coagulation Factor VIII Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Human Coagulation Factor VIII Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Human Coagulation Factor VIII Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Bottle)
Table 45. China Human Coagulation Factor VIII Sales (K Bottles) of Key Companies (2016-2021)
Table 46. China Human Coagulation Factor VIII Sales Share by Company (2016-2021)
Table 47. China Human Coagulation Factor VIII Revenue (US$ Million) by Company (2016-2021)
Table 48. China Human Coagulation Factor VIII Revenue Share by Company (2016-2021)
Table 49. China Human Coagulation Factor VIII Sales (K Bottles) by Type (2016-2021)
Table 50. China Human Coagulation Factor VIII Sales Share by Type (2016-2021)
Table 51. China Human Coagulation Factor VIII Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. China Human Coagulation Factor VIII Price (USD/Bottle) by Type (2016-2021)
Table 53. China Human Coagulation Factor VIII Sales (K Bottles) by Type (2022-2027)
Table 54. China Human Coagulation Factor VIII Sales Share by Type (2022-2027)
Table 55. China Human Coagulation Factor VIII Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. China Human Coagulation Factor VIII Revenue Share by Type (2022-2027)
Table 57. China Human Coagulation Factor VIII Price (USD/Bottle) by Type (2022-2027)
Table 58. China Human Coagulation Factor VIII Sales (K Bottles) by Application (2016-2021)
Table 59. China Human Coagulation Factor VIII Sales Share by Application (2016-2021)
Table 60. China Human Coagulation Factor VIII Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. China Human Coagulation Factor VIII Price (USD/Bottle) by Application (2016-2021)
Table 62. China Human Coagulation Factor VIII Sales (K Bottles) by Application (2022-2027)
Table 63. China Human Coagulation Factor VIII Sales Share by Application (2022-2027)
Table 64. China Human Coagulation Factor VIII Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. China Human Coagulation Factor VIII Revenue Share by Application (2022-2027)
Table 66. China Human Coagulation Factor VIII Price (USD/Bottle) by Application (2022-2027)
Table 67. North America Human Coagulation Factor VIII Sales by Country (2016-2021) & (K Bottles)
Table 68. North America Human Coagulation Factor VIII Sales Market Share by Country (2016-2021)
Table 69. North America Human Coagulation Factor VIII Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Human Coagulation Factor VIII Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Human Coagulation Factor VIII Sales by Region (2016-2021) & (K Bottles)
Table 72. Asia Pacific Human Coagulation Factor VIII Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Human Coagulation Factor VIII Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Human Coagulation Factor VIII Revenue Market Share by Region (2016-2021)
Table 75. Europe Human Coagulation Factor VIII Sales by Country (2016-2021) & (K Bottles)
Table 76. Europe Human Coagulation Factor VIII Sales Market Share by Country (2016-2021)
Table 77. Europe Human Coagulation Factor VIII Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Human Coagulation Factor VIII Revenue Market Share by Country (2016-2021)
Table 79. Latin America Human Coagulation Factor VIII Sales by Country (2016-2021) & (K Bottles)
Table 80. Latin America Human Coagulation Factor VIII Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Human Coagulation Factor VIII Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Human Coagulation Factor VIII Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Human Coagulation Factor VIII Sales by Country (2016-2021) & (K Bottles)
Table 84. Middle East and Africa Human Coagulation Factor VIII Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Human Coagulation Factor VIII Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Human Coagulation Factor VIII Revenue Market Share by Country (2016-2021)
Table 87. Shire (Baxter) Corporation Information
Table 88. Shire (Baxter) Description and Business Overview
Table 89. Shire (Baxter) Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 90. Shire (Baxter) Human Coagulation Factor VIII Product
Table 91. Shire (Baxter) Recent Development
Table 92. Bayer Corporation Information
Table 93. Bayer Description and Business Overview
Table 94. Bayer Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 95. Bayer Product
Table 96. Bayer Recent Development
Table 97. CSL Corporation Information
Table 98. CSL Description and Business Overview
Table 99. CSL Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 100. CSL Product
Table 101. CSL Recent Development
Table 102. Pfizer Corporation Information
Table 103. Pfizer Description and Business Overview
Table 104. Pfizer Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 105. Pfizer Product
Table 106. Pfizer Recent Development
Table 107. Grifols Corporation Information
Table 108. Grifols Description and Business Overview
Table 109. Grifols Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 110. Grifols Product
Table 111. Grifols Recent Development
Table 112. Biogen Corporation Information
Table 113. Biogen Description and Business Overview
Table 114. Biogen Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 115. Biogen Product
Table 116. Biogen Recent Development
Table 117. Octapharma Corporation Information
Table 118. Octapharma Description and Business Overview
Table 119. Octapharma Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 120. Octapharma Product
Table 121. Octapharma Recent Development
Table 122. NovoNordisk Corporation Information
Table 123. NovoNordisk Description and Business Overview
Table 124. NovoNordisk Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 125. NovoNordisk Product
Table 126. NovoNordisk Recent Development
Table 127. Greencross Corporation Information
Table 128. Greencross Description and Business Overview
Table 129. Greencross Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 130. Greencross Product
Table 131. Greencross Recent Development
Table 132. Kedrion Corporation Information
Table 133. Kedrion Description and Business Overview
Table 134. Kedrion Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 135. Kedrion Product
Table 136. Kedrion Recent Development
Table 137. BPL Corporation Information
Table 138. BPL Description and Business Overview
Table 139. BPL Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 140. BPL Product
Table 141. BPL Recent Development
Table 142. Hualan Bio Corporation Information
Table 143. Hualan Bio Description and Business Overview
Table 144. Hualan Bio Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 145. Hualan Bio Product
Table 146. Hualan Bio Recent Development
Table 147. RAAS Corporation Information
Table 148. RAAS Description and Business Overview
Table 149. RAAS Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 150. RAAS Product
Table 151. RAAS Recent Development
Table 152. Human Coagulation Factor VIII Market Trends
Table 153. Human Coagulation Factor VIII Market Drivers
Table 154. Human Coagulation Factor VIII Market Challenges
Table 155. Human Coagulation Factor VIII Market Restraints
Table 156. Human Coagulation Factor VIII Customers List
Table 157. Human Coagulation Factor VIII Distributors List
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Coagulation Factor VIII Product Picture
Figure 2. Global Human Coagulation Factor VIII Sales Market Share by Type in 2020 & 2027
Figure 3. Recombinant Factor VIII Product Picture
Figure 4. Plasma-derived Factor VIII Product Picture
Figure 5. Global Human Coagulation Factor VIII Sales Market Share by Application in 2020 & 2027
Figure 6. Hemophilia A
Figure 7. Spontanous / Trauma
Figure 8. Surgical
Figure 9. Other
Figure 10. Human Coagulation Factor VIII Report Years Considered
Figure 11. Global Human Coagulation Factor VIII Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Human Coagulation Factor VIII Market Size 2016-2027 (US$ Million)
Figure 13. Global Human Coagulation Factor VIII Sales 2016-2027 (K Bottles)
Figure 14. Global Human Coagulation Factor VIII Market Size Market Share by Region: 2021 Versus 2027
Figure 15. Global Human Coagulation Factor VIII Sales Market Share by Region (2016-2021)
Figure 16. Global Human Coagulation Factor VIII Sales Market Share by Region in 2020
Figure 17. Global Human Coagulation Factor VIII Revenue Market Share by Region (2016-2021)
Figure 18. Global Human Coagulation Factor VIII Revenue Market Share by Region in 2020
Figure 19. Global Human Coagulation Factor VIII Sales Share by Manufacturer in 2020
Figure 20. The Top 10 and 5 Players Market Share by Human Coagulation Factor VIII Revenue in 2020
Figure 21. Human Coagulation Factor VIII Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 22. Global Human Coagulation Factor VIII Sales Market Share by Type (2016-2021)
Figure 23. Global Human Coagulation Factor VIII Sales Market Share by Type in 2020
Figure 24. Global Human Coagulation Factor VIII Revenue Market Share by Type (2016-2021)
Figure 25. Global Human Coagulation Factor VIII Revenue Market Share by Type in 2020
Figure 26. Global Human Coagulation Factor VIII Sales Market Share by Application (2016-2021)
Figure 27. Global Human Coagulation Factor VIII Sales Market Share by Application in 2020
Figure 28. Global Human Coagulation Factor VIII Revenue Market Share by Application (2016-2021)
Figure 29. Global Human Coagulation Factor VIII Revenue Market Share by Application in 2020
Figure 30. China Human Coagulation Factor VIII Sales Growth Rate 2016-2027 (K Bottles)
Figure 31. China Human Coagulation Factor VIII Revenue Growth Rate 2016-2027 (US$ Million)
Figure 32. China Human Coagulation Factor VIII Market Share in Global Market 2016-2027
Figure 33. China 5 and 10 Largest Human Coagulation Factor VIII Players Market Share by Revenue in Human Coagulation Factor VIII in 2020
Figure 34. China Human Coagulation Factor VIII Revenue Share by Type (2016-2021)
Figure 35. China Human Coagulation Factor VIII Revenue Growth Rate by Type in 2016 & 2020
Figure 36. China Human Coagulation Factor VIII Revenue Share by Application (2016-2021)
Figure 37. China Human Coagulation Factor VIII Revenue Growth Rate by Application in 2016 & 2020
Figure 38. North America Human Coagulation Factor VIII Sales Growth Rate 2016-2021 (K Bottles)
Figure 39. North America Human Coagulation Factor VIII Revenue Growth Rate 2016-2021 (US$ Million)
Figure 40. North America Human Coagulation Factor VIII Sales Market Share by Country in 2020
Figure 41. North America Human Coagulation Factor VIII Revenue Market Share by Country in 2020
Figure 42. U.S. Human Coagulation Factor VIII Sales Growth Rate (2016-2021) (K Bottles)
Figure 43. U.S. Human Coagulation Factor VIII Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Canada Human Coagulation Factor VIII Sales Growth Rate (2016-2021) (K Bottles)
Figure 45. Canada Human Coagulation Factor VIII Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Europe Human Coagulation Factor VIII Sales Growth Rate 2016-2021 (K Bottles)
Figure 47. Europe Human Coagulation Factor VIII Revenue Growth Rate 2016-2021 (US$ Million)
Figure 48. Europe Human Coagulation Factor VIII Sales Market Share by Country in 2020
Figure 49. Europe Human Coagulation Factor VIII Revenue Market Share by Country in 2020
Figure 50. Germany Human Coagulation Factor VIII Sales Growth Rate (2016-2021) (K Bottles)
Figure 51. Germany Human Coagulation Factor VIII Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. France Human Coagulation Factor VIII Sales Growth Rate (2016-2021) (K Bottles)
Figure 53. France Human Coagulation Factor VIII Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. U.K. Human Coagulation Factor VIII Sales Growth Rate (2016-2021) (K Bottles)
Figure 55. U.K. Human Coagulation Factor VIII Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. Italy Human Coagulation Factor VIII Sales Growth Rate (2016-2021) (K Bottles)
Figure 57. Italy Human Coagulation Factor VIII Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Russia Human Coagulation Factor VIII Sales Growth Rate (2016-2021) (K Bottles)
Figure 59. Russia Human Coagulation Factor VIII Revenue Growth Rate (2016-2021) (US$ Million)
Figure 60. Asia Pacific Human Coagulation Factor VIII Sales Growth Rate 2016-2021 (K Bottles)
Figure 61. Asia Pacific Human Coagulation Factor VIII Revenue Growth Rate 2016-2021 (US$ Million)
Figure 62. Asia Pacific Human Coagulation Factor VIII Sales Market Share by Region in 2020
Figure 63. Asia Pacific Human Coagulation Factor VIII Revenue Market Share by Region in 2020
Figure 64. China Human Coagulation Factor VIII Sales Growth Rate (2016-2021) (K Bottles)
Figure 65. China Human Coagulation Factor VIII Revenue Growth Rate (2016-2021) (US$ Million)
Figure 66. Japan Human Coagulation Factor VIII Sales Growth Rate (2016-2021) (K Bottles)
Figure 67. Japan Human Coagulation Factor VIII Revenue Growth Rate (2016-2021) (US$ Million)
Figure 68. South Korea Human Coagulation Factor VIII Sales Growth Rate (2016-2021) (K Bottles)
Figure 69. South Korea Human Coagulation Factor VIII Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. India Human Coagulation Factor VIII Sales Growth Rate (2016-2021) (K Bottles)
Figure 71. India Human Coagulation Factor VIII Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. Australia Human Coagulation Factor VIII Sales Growth Rate (2016-2021) (K Bottles)
Figure 73. Australia Human Coagulation Factor VIII Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. Taiwan Human Coagulation Factor VIII Sales Growth Rate (2016-2021) (K Bottles)
Figure 75. Taiwan Human Coagulation Factor VIII Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. Indonesia Human Coagulation Factor VIII Sales Growth Rate (2016-2021) (K Bottles)
Figure 77. Indonesia Human Coagulation Factor VIII Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Thailand Human Coagulation Factor VIII Sales Growth Rate (2016-2021) (K Bottles)
Figure 79. Thailand Human Coagulation Factor VIII Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Malaysia Human Coagulation Factor VIII Sales Growth Rate (2016-2021) (K Bottles)
Figure 81. Malaysia Human Coagulation Factor VIII Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Philippines Human Coagulation Factor VIII Sales Growth Rate (2016-2021) (K Bottles)
Figure 83. Philippines Human Coagulation Factor VIII Revenue Growth Rate (2016-2021) (US$ Million)
Figure 84. Vietnam Human Coagulation Factor VIII Sales Growth Rate (2016-2021) (K Bottles)
Figure 85. Vietnam Human Coagulation Factor VIII Revenue Growth Rate (2016-2021) (US$ Million)
Figure 86. Latin America Human Coagulation Factor VIII Sales Growth Rate 2016-2021 (K Bottles)
Figure 87. Latin America Human Coagulation Factor VIII Revenue Growth Rate 2016-2021 (US$ Million)
Figure 88. Latin America Human Coagulation Factor VIII Sales Market Share by Country in 2020
Figure 89. Latin America Human Coagulation Factor VIII Revenue Market Share by Country in 2020
Figure 90. Mexico Human Coagulation Factor VIII Sales Growth Rate (2016-2021) (K Bottles)
Figure 91. Mexico Human Coagulation Factor VIII Revenue Growth Rate (2016-2021) (US$ Million)
Figure 92. Brazil Human Coagulation Factor VIII Sales Growth Rate (2016-2021) (K Bottles)
Figure 93. Brazil Human Coagulation Factor VIII Revenue Growth Rate (2016-2021) (US$ Million)
Figure 94. Argentina Human Coagulation Factor VIII Sales Growth Rate (2016-2021) (K Bottles)
Figure 95. Argentina Human Coagulation Factor VIII Revenue Growth Rate (2016-2021) (US$ Million)
Figure 96. Middle East and Africa Human Coagulation Factor VIII Sales Growth Rate 2016-2021 (K Bottles)
Figure 97. Middle East and Africa Human Coagulation Factor VIII Revenue Growth Rate 2016-2021 (US$ Million)
Figure 98. Middle East and Africa Human Coagulation Factor VIII Sales Market Share by Country in 2020
Figure 99. Middle East and Africa Human Coagulation Factor VIII Revenue Market Share by Country in 2020
Figure 100. Turkey Human Coagulation Factor VIII Sales Growth Rate (2016-2021) (K Bottles)
Figure 101. Turkey Human Coagulation Factor VIII Revenue Growth Rate (2016-2021) (US$ Million)
Figure 102. Saudi Arabia Human Coagulation Factor VIII Sales Growth Rate (2016-2021) (K Bottles)
Figure 103. Saudi Arabia Human Coagulation Factor VIII Revenue Growth Rate (2016-2021) (US$ Million)
Figure 104. U.A.E Human Coagulation Factor VIII Sales Growth Rate (2016-2021) (K Bottles)
Figure 105. U.A.E Human Coagulation Factor VIII Revenue Growth Rate (2016-2021) (US$ Million)
Figure 106. Human Coagulation Factor VIII Value Chain
Figure 107. Channels of Distribution
Figure 108. Distributors Profiles
Figure 109. Bottom-up and Top-down Approaches for This Report
Figure 110. Data Triangulation
Figure 111. Key Executives Interviewed

以下、関連資料のご紹介

ヒト凝固因子VIIの世界及び中国市場

Global and China Human Coagulation Factor VII Market Insights, Forecast to 2027
QY2108PAL8851 2021年7月 128Pages
QYResearch社発行の当調査資料ではグローバルにおけるヒト凝固因子VIIの市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、ヒト凝固因子VIIの種類別市場規模（組換え第VIII因子、血漿由来第VIII因子）、用途別市場規模（血友病A、自...

ヒト凝固第VIII因子の世界市場 2020年

Global Human Coagulation Factor VIII Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
GIR201112076 2020年10月20日 101Pages
本書では、ヒト凝固第VIII因子の世界市場を調査対象にし、ヒト凝固第VIII因子の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（組換え型第VIII因子、血漿由来第VIII因子）、用途別分...

ヒト凝固因子VIIの世界市場 2020年

Global Human Coagulation Factor VII Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
GIR201112075 2020年10月20日 105Pages
本書では、ヒト凝固因子VIIの世界市場を調査対象にし、ヒト凝固因子VIIの市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（組換え型第VIII因子、血漿由来第VIII因子）、用途別分析（血友...

凝固因子濃縮物の世界市場 2020年

Global Coagulation Factor Concentrates Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
GIR201102493 2020年10月20日 101Pages
本書では、凝固因子濃縮物の世界市場を調査対象にし、凝固因子濃縮物の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（第VIII因子、第IX因子、フォンヴィレブランド因子、プロトロンビン複合濃...

第VIII因子欠乏症治療の世界市場 2020年

Global Factor VIII Deficiency Treatment Market 2020 by Company, Regions, Type and Application, Forecast to 2025
GIR201114400 2020年10月 120Pages
本書では、第VIII因子欠乏症治療の世界市場を調査対象にし、第VIII因子欠乏症治療の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（血友病A薬、血友病A阻害剤治療、フォンウィルブランド病治療）、用途別分...

表皮成長因子（EGF）の世界及び中国市場

Global and China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Insights, Forecast to 2027
QY2108PAL8818 2021年6月 132Pages
QYResearch社発行の当調査資料ではグローバルにおける表皮成長因子（EGF）の市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、表皮成長因子（EGF）の種類別市場規模（液体、粉末）、用途別市場規模（EGFクリーム、EGFローション、EG...

世界のトロンボエラストグラフィ凝固分析装置市場インサイト・予測（～2027年）

Global Thromboelastography Coagulation Analyzer Market Insights and Forecast to 2027
QY2108PAL3787 2021年8月 95Pages
本調査資料はトロンボエラストグラフィ凝固分析装置の世界市場の現状について調査・分析し、2027年までの市場を予測しました。トロンボエラストグラフィ凝固分析装置の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（手動式、自動式、半自動式）、用途別市場規模（病院、研究所、その他）、主要地域...

トランスフォーミング増殖因子β1の世界及び中国市場

Global and China Transforming Growth Factor Beta 1 Market Insights, Forecast to 2027
QY2108PAL8947 2021年6月 145Pages
QYResearch社発行の当調査資料ではグローバルにおけるトランスフォーミング増殖因子β1の市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、トランスフォーミング増殖因子β1の種類別市場規模（ピルフェニドン、ガルニセルチブ、その他）、用途別...

世界の半自動凝固分析装置市場インサイト・予測（～2027年）

Global Semi-automatic Coagulation Analyzer Market Insights and Forecast to 2027
QY2108PAL3753 2021年8月 113Pages
本調査資料は半自動凝固分析装置の世界市場の現状について調査・分析し、2027年までの市場を予測しました。半自動凝固分析装置の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（ポータブル型、ベンチトップ型）、用途別市場規模（クリニック、病院、その他）、主要地域別市場規模（北米・アメリカ、...

ヒューマンセントリックライティング・環境照明の世界及び中国市場

Global and China Human Centric Lighting and Environmental Lighting Market Insights, Forecast to 2027
QY2108PAL6994 2021年6月 139Pages
QYResearch社発行の当調査資料ではグローバルにおけるヒューマンセントリックライティング・環境照明の市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、ヒューマンセントリックライティング・環境照明の種類別市場規模（従来型光源、LED光源）...

ヒト凝固第VIII因子の世界市場 2020年 Market Overview The Human Coagulation Factor VIII market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…
ヒト凝固因子VIIの世界市場 2020年 Market Overview The Human Coagulation Factor VII market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…
ヒト凝固因子VIIの世界及び中国市場 Human Coagulation Factor VII is one of the proteins that cause blood to clot in the coagulation cascade. It is an enzyme of the serine protease class. It is sometimes used unlicensed in severe uncontrollable bleeding, although there have been safety concerns. A bio similar form of recombinant activa…
第VIII因子欠乏症治療の世界市場 2020年 Market Overview The global Factor VIII Deficiency Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Factor VIII …
凝固因子濃縮物の世界市場 2020年 Market Overview The global Coagulation Factor Concentrates market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Coagulation F…